Palivizumab 50mg/0.5ml solution for injection vials

SNOMED code: 30319211000001108
Active compound: Palivizumab
Preferred name basis: rINN - Recommended International Non-proprietary
Prescribable: ✅ Yes
Dose form: Discrete
Dose size and units: 0.5 ml, vial
Ingredients: Palivizumab — 100 mg / 1 ml based on ingredient substance
Form & Route: solutioninjection.intramuscular
Solution for injection, Intramuscular
Controlled drug: No Controlled Drug Status

Products

Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd)

Synagis 50mg/0.5ml solution for injection vials

SNOMED code: 30251311000001102
Supplier: AstraZeneca UK Ltd
Licensed as: Medicines - MHRA/EMA
Availability restrictions: None
Licensed route: Intramuscular

Pack name & code	Status	GTIN, EAN barcodes	Price	Prescribing	Reimbursement	Pack
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) 1 vial `30251411000001109` ref. pack	💯 Available Legal category: POM	`8054083007106` 1 Sep 2015 End: 8 Mar 2020`08054083007106` 13 Mar 2019 End: 8 Mar 2020`08054083019321` 9 Mar 2020 End: 3 Sep 2023`08680656080377` 29 Jun 2022 End: 3 Sep 2023`5000456066730` 4 Sep 2023	NHS Indicative Price £306.34	• Personally Administered • Hospital	• Prescription Charges • Dispensing Fees • Special container • Discount not deducted - automatic	—

Reference packs

Palivizumab 50mg/0.5ml solution for injection vials 1 vial

SNOMED code

30251211000001105

Quantity and unit

1 vial

Packs

Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) 1 vial